Thomas C. Boone
54Patents
15h-index
62Co-inventors
87Inventor score
Filing activity: Jan 27, 1988 → Dec 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6586398B1 | Chemically modified novel erythropoietin stimulating protein compositions and methods | Human Necessities | 170 | Expired |
| US6919426B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 106 | Expired |
| US5104651A | Stabilized hydrophobic protein formulations of G-CSF | Emerging Cross-Sectional Technologies | 83 | Expired |
| US6294170A | Composition and method for treating inflammatory diseases | Chemistry; Metallurgy | 62 | Expired |
| US6733753B2 | Composition and method for treating inflammatory diseases | Chemistry; Metallurgy | 53 | Expired |
| US8410043B2 | Stabilized activin IIB receptor polypeptides and uses thereof | Human Necessities | 49 | Active |
| US5849883A | Method for purifying granulocyte colony stimulating factor | Human Necessities | 36 | Expired |
| US7511012B2 | Myostatin binding agents | Physics | 28 | Expired |
| US7488590B2 | Modified peptides as therapeutic agents | Chemistry; Metallurgy | 27 | Expired |
| US7803923B2 | Polynucleotides encoding myostatin binding agents | Physics | 23 | Active |
| US9102731B2 | Human CGRP receptor binding proteins | Physics | 22 | Active |
| US7947809B2 | Compositions and methods relating to glucagon receptor antibodies | Chemistry; Metallurgy | 21 | Active |
| US7008924B1 | VGF fusion polypeptides | Chemistry; Metallurgy | 17 | Expired |
| US8030025B2 | Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US7371559B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 16 | Expired |
| US8124724B2 | Peptides and related molecules that modulate nerve growth factor activity | Human Necessities | 15 | Active |
| US9273114B2 | Stabilized receptor polypeptides and uses thereof | Human Necessities | 14 | Active |
| US8071538B2 | Method of increasing muscle mass by administering a myostatin binding agent | Physics | 14 | Active |
| US7928075B2 | Binding agents which inhibit myostatin | Physics | 14 | Active |
| US5606024A | Canine G-CSF polypeptides and pharmaceutical compositions comprising same | Human Necessities | 13 | Expired |
| US8158759B2 | Compositions and methods relating to glucagon receptor antibodies | Chemistry; Metallurgy | 13 | Active |
| US6849450B2 | Antibodies to the metalloproteinase inhibitor | Chemistry; Metallurgy | 12 | Expired |
| US6617145B2 | DNA molecules encoding fibrinolytically active polypeptide | Chemistry; Metallurgy | 11 | Expired |
| US7348162B2 | Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof | Chemistry; Metallurgy | 10 | Expired |
| US10308704B2 | Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof | Human Necessities | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.